Boston Scientific has stated it is unlikely to meet its 2026 sales forecast due to the ongoing fallout from a cyberattack.
The company’s assessment aligns with reports from Bloomberg.com, which noted that the cyberattack has already hindered Boston Scientific’s ability to achieve its financial targets.
Investor’s Business Daily and Yahoo Finance have both highlighted the cyberattack’s impact on the company’s sales and profit, reinforcing concerns over its operational disruptions.
← Back to Home